Partnerships

Phi Pharma is currently optimising its lead and backup candidates for the initial oncology indications and is currently seeking financial and/or industrial partners to accelerate the preclinical development of these programmes beyond the achievement of in-vivo and ex-vivo proof of concept. Phi Pharma is also open to discussing how our targeting technology could benefit therapeutic assets held by potential partners. 

For partnering inquiries, please contact info@phi-pharma.com.